For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

12th Jul 11

Bronchitol Resubmitted to Australian Pharmaceuticals Benefits Advisory Committee

Pharmaxis today announced that it has resubmitted an application for its cystic fibrosis product Bronchitol to the Pharmaceutical Benefits Advisory Committee for reimbursement on the Australian Pharmaceutical Benefits Scheme.


Read full media release - pdf
5th Jul 11

Re-examination of EU Bronchitol Marketing Application Requested

Pharmaxis today announced that a formal request has been submitted to the Committee for Medicinal Products for Human Use requesting a re-examination of the European Bronchitol marketing application for cystic fibrosis.


Read full media release - pdf